Published in Int J Neuropsychopharmacol on January 16, 2016
The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect? Genes (Basel) (2016) 0.79
Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases. Brain Behav Immun (2017) 0.75
Ketamine Exhibits Different Neuroanatomical Profile After Mammalian Target of Rapamycin Inhibition in the Prefrontal Cortex: the Role of Inflammation and Oxidative Stress. Mol Neurobiol (2016) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 28.61
CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med (1998) 19.03
Toll-like receptors and innate immunity. Nat Rev Immunol (2001) 16.50
From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90
Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol (2007) 12.76
Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol (2010) 11.80
Origin and physiological roles of inflammation. Nature (2008) 11.68
The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol (1989) 9.63
Phylogenetic perspectives in innate immunity. Science (1999) 9.42
Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry (2009) 8.74
A meta-analysis of cytokines in major depression. Biol Psychiatry (2009) 7.16
Biology of interleukin 1. FASEB J (1988) 6.15
Stress-induced immune dysfunction: implications for health. Nat Rev Immunol (2005) 5.75
Adverse childhood experiences and the risk of depressive disorders in adulthood. J Affect Disord (2004) 5.65
Innate immunity: impact on the adaptive immune response. Curr Opin Immunol (1997) 5.62
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol (1984) 5.51
The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology (2000) 5.14
Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A (2003) 5.09
Biological basis of the behavior of sick animals. Neurosci Biobehav Rev (1988) 5.03
Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry (2001) 4.70
Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med (2001) 4.39
The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology (2008) 4.35
Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol (2006) 4.29
Th17 cells in human disease. Immunol Rev (2008) 4.27
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol (2006) 3.84
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry (2002) 3.82
When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry (2003) 3.68
The HPA axis in major depression: classical theories and new developments. Trends Neurosci (2008) 3.47
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry (2001) 3.39
Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A (2005) 3.33
Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res (2002) 3.31
The interface between innate and adaptive immunity. Nat Immunol (2004) 3.28
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry (2008) 3.28
Development in motion: helper T cells at work. Cell (2007) 3.24
IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A (2008) 3.19
Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet (2006) 3.19
The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology (2009) 3.01
Plasticity of CD4(+) FoxP3(+) T cells. Curr Opin Immunol (2009) 2.93
The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med (2006) 2.90
The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun (2001) 2.89
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry (2002) 2.87
Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nat Med (2013) 2.85
Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci (2002) 2.83
Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry (2004) 2.83
Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science (1984) 2.83
A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry (1981) 2.76
Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun (2007) 2.75
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry (2013) 2.68
Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology (2009) 2.63
2. Cytokines and chemokines. J Allergy Clin Immunol (2003) 2.54
Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry (2008) 2.52
T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation. Proc Natl Acad Sci U S A (1981) 2.51
Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci (2002) 2.51
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry (2006) 2.44
Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT (2003) 2.41
Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry (2007) 2.38
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry (2009) 2.36
Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology (2000) 2.36
Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry (1995) 2.35
Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology (2011) 2.31
Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci (1995) 2.28
Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry (2008) 2.28
Tryptophan and the immune response. Immunol Cell Biol (2003) 2.26
Current research trends in early life stress and depression: review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp Neurol (2011) 2.20
The macrophage theory of depression. Med Hypotheses (1991) 2.18
Depression and sensitization to stressors among young women as a function of childhood adversity. J Consult Clin Psychol (2000) 2.15
The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology (2011) 2.15
The cholinergic anti-inflammatory pathway. Brain Behav Immun (2005) 2.13
The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology (2006) 2.12
Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev (2003) 2.12
T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol (2000) 2.08
Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neuropsychiatr Genet (2005) 2.05
Neurobiological consequences of childhood trauma. J Clin Psychiatry (2004) 2.00
Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res (2005) 1.96
Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry (2007) 1.93
Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs (2005) 1.93
Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience (2005) 1.92
Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med (1997) 1.92
Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci (2008) 1.88
Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis. J Clin Psychiatry (2011) 1.83
Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci U S A (2001) 1.82
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. J Clin Invest (1994) 1.81
Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior. J Immunol (2009) 1.77
T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol Rev (2011) 1.69
Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res (1998) 1.67
Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol (2002) 1.67
Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord (1995) 1.65
The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res (2000) 1.64
Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience (2003) 1.64
A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry (2009) 1.64
Mechanisms of glucocorticoid receptor signaling during inflammation. Mech Ageing Dev (2004) 1.61
Multiple sclerosis and depression. Mult Scler (2011) 1.60
Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav (2003) 1.60
The contribution of failing adult hippocampal neurogenesis to psychiatric disorders. Curr Opin Psychiatry (2008) 1.60
Depressive symptoms and survival of patients with coronary artery disease. Psychosom Med (2001) 1.59
Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation. Proc Natl Acad Sci U S A (2000) 1.59
Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord (2006) 1.58
Cytokine, sickness behavior, and depression. Neurol Clin (2006) 1.58